07/23/2024 3:47 PM | Cytokinetics (Issuer) Malik Fady Ibraham (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/23/2024 3:21 PM | Cytokinetics (Subject) Malik Fady Ibraham (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 4:05 PM | Cytokinetics (Issuer) PARSHALL B LYNNE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2024 3:11 PM | Cytokinetics (Subject) PARSHALL B LYNNE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 4:24 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/09/2024 5:15 PM | Cytokinetics (Issuer) Malik Fady Ibraham (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/09/2024 3:06 PM | Cytokinetics (Subject) Malik Fady Ibraham (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
07/08/2024 4:06 PM | Cytokinetics (Issuer) Harrington Robert Arthur (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 3:03 PM | Cytokinetics (Subject) Harrington Robert Arthur (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024 7:00 PM | Cytokinetics (Issuer) Harrington Robert Arthur (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 7:02 PM | Cytokinetics (Issuer) HENDERSON JOHN T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 7:04 PM | Cytokinetics (Issuer) Kaye Edward M. MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 7:05 PM | Cytokinetics (Issuer) WIERENGA WENDALL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 7:07 PM | Cytokinetics (Issuer) Wysenski Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 4:12 PM | Cytokinetics (Issuer) PARSHALL B LYNNE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 4:26 PM | Cytokinetics (Subject) PARSHALL B LYNNE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024 3:43 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2024 7:04 PM | Cytokinetics (Issuer) Malik Fady Ibraham (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:39 PM | Cytokinetics (Subject) Malik Fady Ibraham (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 4:13 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 4:17 PM | Cytokinetics (Issuer) PARSHALL B LYNNE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 4:22 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 3:24 PM | Cytokinetics (Subject) PARSHALL B LYNNE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 4:16 PM | Cytokinetics (Subject) Malik Fady Ibraham (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024 4:08 PM | Bhanji Muna (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 4:13 PM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2024 4:23 PM | Cytokinetics (Issuer) Harrington Robert Arthur (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 9:02 AM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 3:30 PM | Cytokinetics (Issuer) PARSHALL B LYNNE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:36 PM | Cytokinetics (Subject) PARSHALL B LYNNE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 3:33 PM | Cytokinetics (Issuer) Wong Robert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 3:15 PM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2024 4:59 PM | Cytokinetics (Issuer) Wysenski Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 5:00 PM | Cytokinetics (Issuer) WIERENGA WENDALL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 5:01 PM | Cytokinetics (Issuer) PARSHALL B LYNNE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 5:03 PM | Cytokinetics (Issuer) Kaye Edward M. MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 5:04 PM | Cytokinetics (Issuer) HENDERSON JOHN T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 5:05 PM | Cytokinetics (Issuer) Harrington Robert Arthur (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 5:06 PM | COSTA SANTO J (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 5:17 PM | Bhanji Muna (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2024 6:00 AM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
The #1 Crypto for 2024 (3 Cent Coin) (Ad) Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017…
And has spotted 44 different coins that have returned over 100%...
Today, he is now making the biggest crypto call of his ENTIRE career…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8483&Placement=NativeDisplay&Source=NativeDisplay) Click For My #1 FREE Crypto for 2024 |
05/08/2024 6:05 AM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 3:37 PM | Cytokinetics (Issuer) Malik Fady Ibraham (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 4:30 PM | Cytokinetics (Issuer) Lee Sung (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/25/2024 5:54 PM | Cytokinetics (Issuer) HENDERSON JOHN T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 3:38 PM | Cytokinetics (Issuer) Malik Fady Ibraham (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 3:35 PM | Cytokinetics (Filer)
| Form DEF 14A | |
04/08/2024 3:37 PM | Cytokinetics (Filer)
| Form ARS | |
04/05/2024 6:30 AM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 5:57 PM | Cytokinetics (Issuer) Malik Fady Ibraham (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 6:02 PM | Callos Andrew (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 6:07 PM | Cytokinetics (Issuer) Wong Robert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 5:52 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:26 PM | Cytokinetics (Issuer) Wong Robert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:50 AM | Cytokinetics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024 3:43 PM | Cytokinetics (Issuer) Malik Fady Ibraham (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:38 PM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 3:41 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 9:45 AM | Cytokinetics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024 4:19 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 1:03 PM | BlackRock Inc. (Filed by) Cytokinetics (Subject)
| Form SC 13G/A | |
01/19/2024 3:49 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 4:20 PM | Cytokinetics (Issuer) HENDERSON JOHN T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 3:09 PM | Cytokinetics (Subject) HENDERSON JOHN T (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 3:02 PM | Cytokinetics (Subject) Malik Fady Ibraham (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 4:55 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:19 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023 3:10 PM | Cytokinetics (Subject) WIERENGA WENDALL (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023 3:11 PM | Cytokinetics (Issuer) WIERENGA WENDALL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 6:30 AM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2023 4:22 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2023 3:21 PM | Cytokinetics (Subject) Malik Fady Ibraham (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/03/2023 4:30 PM | Cytokinetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/30/2023 3:48 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023 6:32 AM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2023 4:57 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2023 3:18 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/12/2023 5:39 PM | Cytokinetics (Issuer) Malik Fady Ibraham (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:22 PM | Cytokinetics (Subject) Malik Fady Ibraham (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/06/2023 3:52 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 3:32 PM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 3:09 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2023 3:13 PM | Cytokinetics (Issuer) Wysenski Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 8:06 PM | Cytokinetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/14/2023 3:09 PM | Cytokinetics (Issuer) Malik Fady Ibraham (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/14/2023 3:18 PM | Cytokinetics (Subject) Malik Fady Ibraham (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:09 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 3:09 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2023 5:45 PM | Blum Robert I (Reporting) Cytokinetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 3:33 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 3:38 PM | Cytokinetics (Subject) WIERENGA WENDALL (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Collapse of the Petrodollar (Ad) The death of the "petrodollar" seems imminent.
And the implications could not be worse for Americans.
Russia, China and India have decided to abandon the petrodollar.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8418&Placement=NativeDisplay&Source=NativeDisplay) In answer to this issue, we have released a Special Report to the public. |
08/11/2023 4:32 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023 4:18 PM | Cytokinetics (Subject) Malik Fady Ibraham (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023 3:14 PM | Cytokinetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023 3:25 PM | Blum Robert I (Reporting) Cytokinetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |